• Blog
  • Intrauterine Contraceptive Market Report

    Intrauterine Contraceptive Market Report

    Intrauterine Contraceptive Market Report
    Report code - SR1492 Delivery - 2 Weeks
    Get Free Sample |
    Intrauterine Contraceptive Market Trends, Dynamics & Market Insights
    See more...

    Market Insights

    The Intrauterine Contraceptive Market is estimated to grow from USD xx million in 2020 to USD xx million by 2026 at a healthy CAGR of 10.2% during the forecast period.

    Figure: Intrauterine Contraceptive Market Size, 2020-2026 (USD Million)

    Intrauterine-Contraceptive-Market-Forecast

    Wish to get a free sample? Register Here

    What is an intrauterine device?

    An intrauterine device (IUD) is a small contraceptive device, usually 'T'-shaped, consisting of either copper or levonorgestrel, which is inserted into the uterus. It is one form of long-acting reversible contraception, which is the most effective type of reversible birth control.

    Key Players

    Key players operating in the intrauterine contraceptive market are-

    • Abbvie Inc (Allergan Plc) (US)
    • Bayer AG (Germany)
    • CooperSurgical Inc. (US)
    • DKT International (US)
    • EUROGINE, S.L (Luxembourg)
    • Mona Lisa NV (Belgium)
    • Pregna International Limited (India)
    • Prosan International BV (Netherlands)
    • SMB Corporation of India (India)
    • Melbea AG (US).

    Market Dynamics

    The key factors include the technological innovations resulting ineffective contraception and fewer side effects, the rising rate of unintended pregnancies, and supportive government initiatives & private firms for the prevention of unwanted abortions and pregnancies, which boosts the market growth. Also, the market is largely driven by the growing rate of unintended pregnancies and unwanted abortions. Moreover, the long-term efficacy and rising acceptance are likely to augment the growth of the intrauterine contraceptive devices market.

    Segments' Analysis

    Device Trends

    Based on the device, the market has been classified into hormonal intrauterine and copper intrauterine. The copper intrauterine segment accounted for a substantial market share in 2020. Copper IUDs have been in the market for a very long time, since 1988, earlier than the hormonal IUDs. One of the benefits of using copper IUDs is that they can be used as emergency contraceptives. Also, they can be used within five days of unprotected intercourse to avoid pregnancy.

    Regional Trends

    The market in North America accounted for the largest share in 2020 and is projected to continue its dominance during the review period. This is mainly attributed to the large presence of advanced healthcare infrastructure, rise in demand for intrauterine contraceptives, as well as presence of major market participants. IUDs are one of the most effective forms of reversible contraception, and the interest in this method is rising among women and healthcare providers in the region. The US has shown the greatest demand in the use of both hormone-free copper, as well as hormone-based IUDs, which further proliferates regional growth.

    COVID-19 Impact on Intrauterine Contraceptive Market

    The COVID-19 outbreak negatively affected the growth of the Intrauterine Contraceptive market. During the pandemic with rising cases of COVID-19 across the globe, the health care emphasis has shifted to focus on the apportionment of resources, emergent medical care, prevention of viral spread, and the development of novel treatments and vaccines. Moreover, the unfortunate by-product of this shift is the de-prioritization of other essential health care services such as access to contraception, thus affecting the industry's growth.

    • What are the key trends in the intrauterine contraceptive market?
    • How the market (and its various sub-segments) has grown in the last five years and what would be the growth rate in the next five years?
    • What is the impact of COVID-19 on the intrauterine contraceptive market?
    • What are the key strategies adopted by the major vendors to lead in the intrauterine contraceptive market?
    • What is the market share of the top vendors?

    Get the full scope of the report. Register Here

    Target Audience

    Here is the list of the group of customers that the intrauterine contraceptive market hopes to have the greatest opportunity to convert-

    • Intrauterine Contraceptive distributors
    • Intrauterine Contraceptive suppliers
    • Intrauterine Contraceptive manufacturers
    • Hospitals
    • Government bodies

    Custom Research: Stratview research offers custom research services across sectors. In case of any custom research requirement related to market assessment, competitive benchmarking, sourcing and procurement, target screening, and others, please send your inquiry at sales@stratviewresearch.com.

    Frequently Asked Questions (FAQs)

    The intrauterine contraceptive market is expected to witness an impressive growth of 10.2% CAGR in the coming years.

    Abbvie Inc (Allergan Plc) (US), Bayer AG (Germany), CooperSurgical Inc. (US), DKT Internation-al (US), EUROGINE, S.L (Luxembourg), Mona Lisa NV (Belgium), Pregna International Limited (India), Prosan International BV (Netherlands), SMB Corporation of India (India), and Melbea AG (US) are among the key players in the intrauterine contraceptive market.

    The technological innovations resulting ineffective contraception and fewer side effects, the rising rate of unintended pregnancies are the factors driving the growth of intrauterine contraceptive market.

    The copper intrauterine segment accounted for the substantial share in the intrauterine contraceptive market in 2020.

    North America is expected to remain dominant in the intrauterine contraceptive market in the next five years.

    Intrauterine Contraceptive distributors, Intrauterine Contraceptive suppliers, Intrauterine Contraceptive manufacturers, Hospitals, Government bodies are the target audience in the intrauterine contraceptive market.

    •   
    ×